SIC 3851
Ophthalmic Goods
7 companies · 1 with disclosed financials
Total revenue (latest)
$1.02B
Total net income
$130.8M
Avg net margin
12.8%
Median net margin
12.8%
5-year industry trend
Total revenue summed across 2 companies in the most recent fiscal year. Median margin is the cross-sectional median per year.
Largest by revenue
- 1COOCOOPER COMPANIES, INC.
$12.20B cap · 12.8% margin · as of 2026-01-31
$1.02B
revenue
- 2BLCOBausch & Lomb Corp
$5.68B cap
—
revenue
- 3WRBYWarby Parker Inc.
$2.77B cap
—
revenue
- 4EYENational Vision Holdings, Inc.
$1.36B cap
—
revenue
- 5RXSTRxSight, Inc.
—
revenue
- 6LUCYInnovative Eyewear Inc
—
revenue
- 7STAASTAAR SURGICAL CO
$1.64B cap
—
revenue
Insider activity in this industry · last 12 months
Insider buying
$68.1M
Insider selling
$48.4M
Net flow
+$19.7M
Distinct insiders
31
Open-market trades summed across all 4 companies in the industry where insiders bought. Sales counted across all companies regardless. Filed via SEC Form 4.
Recently filed in this industry
Related industries
Surgical & Medical Instruments & Apparatus
SIC 3841 · 14 cos
Industrial Instruments For Measurement, Display, and Control
SIC 3823 · 5 cos
Laboratory Analytical Instruments
SIC 3826 · 4 cos
Measuring & Controlling Devices, NEC
SIC 3829 · 3 cos
Optical Instruments & Lenses
SIC 3827 · 2 cos
Electromedical & Electrotherapeutic Apparatus
SIC 3845 · 2 cos
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
SIC 3844 · 1 cos
Watches, Clocks, Clockwork Operated Devices/Parts
SIC 3873 · 1 cos
About the Ophthalmic Goods industry on ActaClear
ActaClear tracks 7 US-listed public companies classified under SEC SIC code 3851 (Ophthalmic Goods). Combined latest-period revenue across the sector is $1.02B, with a median net margin of 12.8% per company.
Every name on this page links to a full company dashboard with 5-year SEC financials, live market data, ratios, AI-summarised business description, insider transactions, and institutional ownership. Data is sourced directly from SEC EDGAR XBRL filings and refreshed continuously.